Esperite's ESP The Cell Factory received European funding to develop the 2nd generation EVs drug for treatment of Stroke

Esperite's biotech company The Cell Factory Belgium has received funding from the European Union's Horizon 2020 research and innovation Programme for development and characterization of the extracellular vesicles EVs drug CFMEV126 for...